Skip to content

CVSA

Covista Inc.

NYSE · Consumer Cyclical · Personal Products & Services · US

$124.19
+1.35%
Ask drillr

Year over year

Reported trailing growth

Revenue
+9.3%
EBITDA
+10.3%
EBIT
+13.2%
EPS
+18.5%
Free cash flow
+9.7%
Operating cash flow
+19.7%

Forward estimates

Based on analyst estimates

Revenue
+5.6%
EBITDA
-1.7%
EPS
+16.4%

Three-year CAGR

Revenue
+10.4%
EBITDA
+10.9%
EBIT
+19.2%
Net income
+37.4%
EPS
+49.8%
Free cash flow
+33.3%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026